Skip to main content

Want a detailed portfolio tracker?

MBX Biosciences (MBX) P/E (2024 - 2026)

MBX Biosciences (MBX) P/E from Sep 30, 2024 to Jul 21, 2026. The TTM MBX Biosciences (MBX) P/E is -17.26. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MBX Biosciences (MBX)

YearP/EChange
2026-17.26+103.16%
2025-8.50-53.44%
2024-18.25N/A

Comparison MBX Biosciences (MBX) P/E with competitors

MBX Biosciences (MBX) P/E is -17.26.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.43%
FGENFibroGen Inc0.24-101.39%
CHRSCoherus Biosciences Inc0.85-104.92%
FBIOFortress Biotech Inc0.95-105.50%
ORMPOramed Pharmaceuticals Inc1.50-108.71%
AGENAgenus Inc3.01-117.43%
INVAInnoviva Inc3.15-118.27%
VXRTVaxart Inc3.55-120.56%
CRMDCorMedix Inc3.63-121.02%
CVACCureVac N.V.4.45-125.75%
GLPGGalapagos NV4.86-128.15%
SRPTSarepta Therapeutics Inc4.88-128.28%
ABEOAbeona Therapeutics Inc5.39-131.21%
ABUSArbutus Biopharma Corp5.60-132.42%
ZVRAZevra Therapeutics Inc5.89-134.10%
SPROSpero Therapeutics Inc6.23-136.08%
CGENCompugen Ltd6.31-136.58%
RIGLRigel Pharmaceuticals6.87-139.81%
SLXNSilexion Therapeutics Corp7.30-142.27%
OMEROmeros Corporation9.26-153.64%
AUPHAurinia Pharmaceuticals Inc9.58-155.53%
PLXProtalix BioTherapeutics Inc10.89-163.09%
ACADAcadia Pharmaceuticals Inc11.73-167.94%
TBPHTheravance Biopharma Inc12.26-171.04%
ADMAAdma Biologics Inc12.42-171.94%
HRMYHarmony Biosciences Holdings Inc13.82-180.06%
SABSSAB Biotherapeutics Inc14.14-181.89%
NAGENiagen Bioscience Inc14.82-185.84%
INCYIncyte Corp15.82-191.66%
REGNRegeneron Pharmaceuticals Inc15.86-191.86%
PBYIPuma Biotechnology Inc17.32-200.31%
CPRXCatalyst Pharmaceuticals Inc17.44-201.03%
EXELExelixis Inc17.54-201.60%
TGTXTG Therapeutics Inc18.97-209.87%
MDXGMimedx Group Inc20.55-219.06%
XOMAXOMA Royalty Corp22.87-232.52%
ARGXArgen X SE24.30-240.76%
CTMXCytomX Therapeutics Inc24.82-243.79%
XOMAOXOMA Royalty Corp25.34-246.83%
HALOHalozyme Therapeutics Inc25.62-248.44%
XOMAPXOMA Royalty Corp25.67-248.71%
VRTXVertex Pharmaceuticals Inc27.99-262.18%
RPRXRoyalty Pharma plc - Class A28.69-266.19%
SLNOSoleno Therapeutics Inc29.02-268.09%
ASNDAscendis Pharma A/S30.09-274.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-319.63%
APLSApellis Pharmaceuticals Inc39.02-326.06%
BMRNBiomarin Pharmaceutical Inc42.21-344.54%
KRYSKrystal Biotech Inc45.34-362.68%
ONCBeiGene Ltd69.54-502.86%
PHARPharming Group N.V.75.03-534.64%
TECHBio-Techne Corp101.96-690.67%
VCELVericel Corp109.92-736.80%
ALNYAlnylam Pharmaceuticals Inc117.96-783.40%
GMABGenmab140.29-912.73%
TLXTelix Pharmaceuticals Ltd162.15-1039.38%
CORTCorcept Therapeutics Inc212.86-1333.13%